These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 6345130)

  • 41. Plasma/serum protein binding determinations.
    Banker MJ; Clark TH
    Curr Drug Metab; 2008 Nov; 9(9):854-9. PubMed ID: 18991581
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Biochemical principles, therapeutic significance and prevention of drug interactions on the pharmacokinetic level].
    Remmer H
    Internist (Berl); 1979 May; 20(5):213-24. PubMed ID: 376477
    [No Abstract]   [Full Text] [Related]  

  • 43. Protein binding of drugs.
    Heald AF; Singhvi SM
    Ann Clin Lab Sci; 1978; 8(3):239-43. PubMed ID: 655609
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Kinetics of drug displacement interactions.
    Aarons LJ; Rowland M
    J Pharmacokinet Biopharm; 1981 Apr; 9(2):181-90. PubMed ID: 7277208
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Characterization of propofol binding to plasma proteins and possible interactions].
    Garrido MJ; Jiménez RM; Rodríguez-Sasiaín JM; Aguirre C; Aguilera L; Calvo R
    Rev Esp Anestesiol Reanim; 1994; 41(6):308-12. PubMed ID: 7838996
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetics in the elderly.
    Crooks J; O'Malley K; Stevenson IH
    Clin Pharmacokinet; 1976; 1(4):280-96. PubMed ID: 797500
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lack of pharmacokinetic interaction for ISIS 113715, a 2'-0-methoxyethyl modified antisense oligonucleotide targeting protein tyrosine phosphatase 1B messenger RNA, with oral antidiabetic compounds metformin, glipizide or rosiglitazone.
    Geary RS; Bradley JD; Watanabe T; Kwon Y; Wedel M; van Lier JJ; VanVliet AA
    Clin Pharmacokinet; 2006; 45(8):789-801. PubMed ID: 16884318
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Representation and interpretation of drug displacement interactions.
    Schary WL; Aarons LJ; Rowland M
    Biochem Pharmacol; 1978 Jan; 27(1):139-44. PubMed ID: 619901
    [No Abstract]   [Full Text] [Related]  

  • 49. Protein binding and kinetics of drugs in liver diseases.
    Blaschke TF
    Clin Pharmacokinet; 1977; 2(1):32-44. PubMed ID: 322909
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Drug metabolism and pharmacokinetics in malnourished children.
    Krishnaswamy K
    Clin Pharmacokinet; 1989; 17 Suppl 1():68-88. PubMed ID: 2692941
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fosphenytoin: clinical pharmacokinetics and comparative advantages in the acute treatment of seizures.
    Fischer JH; Patel TV; Fischer PA
    Clin Pharmacokinet; 2003; 42(1):33-58. PubMed ID: 12489978
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Microseparation techniques for the study of the enantioselectivity of drug-plasma protein binding.
    Escuder-Gilabert L; Martínez-Gómez MA; Villanueva-Camañas RM; Sagrado S; Medina-Hernández MJ
    Biomed Chromatogr; 2009 Mar; 23(3):225-38. PubMed ID: 19016227
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro, in silico and integrated strategies for the estimation of plasma protein binding. A review.
    Lambrinidis G; Vallianatou T; Tsantili-Kakoulidou A
    Adv Drug Deliv Rev; 2015 Jun; 86():27-45. PubMed ID: 25819487
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Calcium antagonists. Pharmacokinetic properties.
    Kates RE
    Drugs; 1983 Feb; 25(2):113-24. PubMed ID: 6339196
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The pharmacokinetics of antiarrhythmic agents in pregnancy and lactation.
    Mitani GM; Steinberg I; Lien EJ; Harrison EC; Elkayam U
    Clin Pharmacokinet; 1987 Apr; 12(4):253-91. PubMed ID: 3297463
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Valproic acid: in vitro plasma protein binding and interaction with phenytoin.
    Cramer JA; Mattson RH
    Ther Drug Monit; 1979; 1(1):105-16. PubMed ID: 121944
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Age-related changes in protein binding of drugs: implications for therapy.
    Grandison MK; Boudinot FD
    Clin Pharmacokinet; 2000 Mar; 38(3):271-90. PubMed ID: 10749520
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Plasma protein binding of drugs in the elderly.
    Wallace SM; Verbeeck RK
    Clin Pharmacokinet; 1987 Jan; 12(1):41-72. PubMed ID: 3545616
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The binding of drugs to plasma proteins from patients with poor renal function.
    Reidenberg MM
    Clin Pharmacokinet; 1976; 1(2):121-5. PubMed ID: 797494
    [TBL] [Abstract][Full Text] [Related]  

  • 60. First-pass elimination. Basic concepts and clinical consequences.
    Pond SM; Tozer TN
    Clin Pharmacokinet; 1984; 9(1):1-25. PubMed ID: 6362950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.